로딩 중…
지수 로딩 중…
CHONGKUNDANG HOLDINGS CORP.
001630· KOSPI· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
₩40,350-1.82%
2026-06-19
Price Chart
CHONGKUNDANG HOLDINGS CORP.-24.44%
Financials
Investment Metrics(as of 2026-06-19)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | 202.15B KRW |
| Revenue | 952.66B KRW |
| Net Income | 66.28B KRW |
| Total Assets | 1.68T KRW |
| Net Assets | 923.72B KRW |
| Employees | 37 |
| Value | |
| P/E | 3.05x |
| P/B | 0.22x |
| PEG | 0.02x |
| P/S | 0.21x |
| EV/EBITDA | 11.07x |
| FCF Yield | 9.99% |
| Profitability | |
| ROE | 7.17% |
| ROA | 3.95% |
| Op. Margin | 6.89% |
| Revenue Growth | -2.58% |
| Earnings Growth | 201.38% |
| Financial Health | |
| Debt Ratio | 81.76% |
| Total Debt | 562.67B KRW |
| FCF | 20.20B KRW |
| Cash | 37.72B KRW |
| Current Ratio | 0.83x |
| Net Debt/EBITDA | 8.00x |
| Dividend | |
| Div. Yield | 3.41% |
| Div. Growth | 0.00% |
| Performance | |
| 1Y Return | -24.44% |
| 1M Return | -11.22% |
| From 52W High | -31.96% |
| 1Y MDD | -28.10% |
| Trading | |
| Volume | 14,850 shares |
| Foreign Own. | 3.47% |
| Per Share | |
| EPS | 9,457 KRW |
| BPS | 136,062 KRW |
Company Info
Jonggeundang Holdings, established in 1941, became a registered pharmaceutical company in 1956 before transitioning to a holding company structure in 2013 through a spin-off of its investment and pharmaceutical divisions. As a holding company, its main revenue sources are management consulting fees, brand usage fees, and dividend income, with a focus on governance and management through subsidiary equity ownership. It manages key subsidiaries such as Jonggeundang Health, Gyeongbo Pharmaceutical, Jonggeundang Bio, and Jonggeundang Industrial, along with its subsidiary Jonggeundang, fostering synergy and value through independent management and performance evaluation. The company is headquartered in Seodaemun-gu, Seoul Metropolitan City.